In India, skin troubles often go unnoticed until they’re too loud to ignore. Between harsh sun, dust, stress, and everyday neglect, fine lines, dullness, and stubborn blemishes arrive earlier than expected. Beneath them, something more persistent lurks — senescent cells.
These damaged, aging cells refuse to move on. Instead, they linger, triggering inflammation and slowing down skin’s ability to repair. Scientists fittingly call them ‘zombie cells.’
Now, a new experimental cream called RLS-1496 is in its first human trial. Not a fairness promise, not a glow-up trend — this one’s built to quietly clear out those dead-weight cells, giving skin a fair chance to heal and reset.
Rubedo doses first patient in trial targeting senescent skin cells
Lab results so far suggest it might ease stubborn conditions like psoriasis and severe inflammation too. If it works in people, it could do more than soften lines; it might help slow the wear we’ve long learned to live with.
Vader Top Dog